A to Z / Approved medicine
Abaloparatide
Also known as Tymlos, PTHrP analogue.
Best known for The other bone-building peptide
Evidence★★★★★
Safety dataWell characterised
Route daily subcutaneous injection via pen
United StatesFDA approved
AustraliaSchedule 4: prescription only
as at 16 September 2026
What it is and what it does
Abaloparatide is a synthetic analogue of parathyroid hormone-related protein, and an approved medicine. It is used to build bone and reduce fracture risk in osteoporosis where fracture risk is high.
What the full entry covers
The book carries the rest of this entry:
- Where the research stands, with every claim cited
- What people commonly ask, and what the research shows so far
- Dosing in four labelled bands, described and not recommended
- Side effects, serious risks, cautions and interactions
- Questions to discuss with your doctor
- How it compares with Teriparatide, Calcitonin
Related entries
A certificate of analysis tells you what is in a vial. The evidence rating above tells you whether the compound has been shown to work in humans. Neither answers the other's question. How to read a certificate of analysis.
This page describes what is known and not known about Abaloparatide. It is not medical advice and not a recommendation to use it.